-
1
-
-
84905919452
-
Calcium signaling in Parkinson's disease
-
Calì T, Ottolini D, Brini M. Calcium signaling in Parkinson's disease. Cell Tissue Res. 2014; 357:439-54
-
(2014)
Cell Tissue Res
, vol.357
, pp. 439-454
-
-
Calì, T.1
Ottolini, D.2
Brini, M.3
-
2
-
-
65349159205
-
Calcium homeostasis, selective vulnerability and Parkinson's disease
-
Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci. 2009; 32:249-56
-
(2009)
Trends Neurosci
, vol.32
, pp. 249-256
-
-
Chan, C.S.1
Gertler, T.S.2
Surmeier, D.J.3
-
3
-
-
77549084979
-
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
-
Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium. 2010; 47:175-82
-
(2010)
Cell Calcium
, vol.47
, pp. 175-182
-
-
Surmeier, D.J.1
Guzman, J.N.2
Sanchez-Padilla, J.3
-
4
-
-
84922241473
-
Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization
-
Hurley MJ, Gentleman SM, Dexter DT. Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization. J Mol Neurosci. 2015; 55:715-24
-
(2015)
J Mol Neurosci
, vol.55
, pp. 715-724
-
-
Hurley, M.J.1
Gentleman, S.M.2
Dexter, D.T.3
-
5
-
-
84906417439
-
Original Papers: On The Occurrence Of Abnormal Deposits Of Iron In The Brain In Parkinsonism With Special Reference To Its Localisation
-
Lhermitte J, Kraus WM, McAlpine D. Original Papers: On The Occurrence Of Abnormal Deposits Of Iron In The Brain In Parkinsonism With Special Reference To Its Localisation. J Neurol Psychopathol. 1924; 5:195-208.
-
(1924)
J Neurol Psychopathol
, vol.5
, pp. 195-208
-
-
Lhermitte, J.1
Kraus, W.M.2
McAlpine, D.3
-
6
-
-
0024557734
-
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
-
Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989; 52:515-20.
-
(1989)
J Neurochem
, vol.52
, pp. 515-520
-
-
Riederer, P.1
Sofic, E.2
Rausch, W.D.3
Schmidt, B.4
Reynolds, G.P.5
Jellinger, K.6
Youdim, M.B.7
-
7
-
-
0037121688
-
Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia
-
Grant RJ, Clarke PB. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia. Neuroscience. 2002; 115:1281-94.
-
(2002)
Neuroscience
, vol.115
, pp. 1281-1294
-
-
Grant, R.J.1
Clarke, P.B.2
-
8
-
-
3042794162
-
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
-
McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol. 2004; 56:149-62.
-
(2004)
Ann Neurol
, vol.56
, pp. 149-162
-
-
McNaught, K.S.1
Perl, D.P.2
Brownell, A.L.3
Olanow, C.W.4
-
9
-
-
33749506725
-
Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload
-
Jiang H, Luan Z, Wang J, Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int. 2006; 49:605-9.
-
(2006)
Neurochem Int
, vol.49
, pp. 605-609
-
-
Jiang, H.1
Luan, Z.2
Wang, J.3
Xie, J.4
-
10
-
-
33747441863
-
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
-
Maingay M, Romero-Ramos M, Carta M, Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol Dis. 2006; 23:522-32.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 522-532
-
-
Maingay, M.1
Romero-Ramos, M.2
Carta, M.3
Kirik, D.4
-
11
-
-
0038454676
-
Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes
-
Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003; 60:1761-6.
-
(2003)
Neurology
, vol.60
, pp. 1761-1766
-
-
Powers, K.M.1
Smith-Weller, T.2
Franklin, G.M.3
Longstreth, W.T.4
Swanson, P.D.5
Checkoway, H.6
-
12
-
-
36549039631
-
Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12
-
Meng H, Li C, Feng L, Cheng B, Wu F, Wang X, Li Z, Liu S. Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12. Int J Dev Neurosci. 2007; 25:509-14.
-
(2007)
Int J Dev Neurosci
, vol.25
, pp. 509-514
-
-
Meng, H.1
Li, C.2
Feng, L.3
Cheng, B.4
Wu, F.5
Wang, X.6
Li, Z.7
Liu, S.8
-
13
-
-
84861461822
-
L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats
-
Wang R, Ma Z, Wang J, Xie J. L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats. Neurotox Res. 2012; 21:266-70.
-
(2012)
Neurotox Res
, vol.21
, pp. 266-270
-
-
Wang, R.1
Ma, Z.2
Wang, J.3
Xie, J.4
-
14
-
-
84903952294
-
Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons
-
Branch SY, Sharma R, Beckstead MJ. Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons. J Neurosci. 2014; 34:9310-8.
-
(2014)
J Neurosci
, vol.34
, pp. 9310-9318
-
-
Branch, S.Y.1
Sharma, R.2
Beckstead, M.J.3
-
15
-
-
79958204001
-
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
-
Ilijic E, Guzman JN, Surmeier DJ. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. Neurobiol Dis. 2011; 43:364-71.
-
(2011)
Neurobiol Dis
, vol.43
, pp. 364-371
-
-
Ilijic, E.1
Guzman, J.N.2
Surmeier, D.J.3
-
16
-
-
84905914398
-
The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function
-
Berger SM, Bartsch D. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res. 2014; 357:463-76.
-
(2014)
Cell Tissue Res
, vol.357
, pp. 463-476
-
-
Berger, S.M.1
Bartsch, D.2
-
17
-
-
71849099262
-
Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons
-
Putzier I, Kullmann PH, Horn JP, Levitan ES. Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J Neurosci. 2009; 29:15414-9.
-
(2009)
J Neurosci
, vol.29
, pp. 15414-15419
-
-
Putzier, I.1
Kullmann, P.H.2
Horn, J.P.3
Levitan, E.S.4
-
18
-
-
84942057993
-
Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice
-
Poetschke C, Dragicevic E, Duda J, Benkert J, Dougalis A, DeZio R, Snutch TP, Striessnig J, Liss B. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice. Sci Rep. 2015; 5:13688.
-
(2015)
Sci Rep
, vol.5
, pp. 13688
-
-
Poetschke, C.1
Dragicevic, E.2
Duda, J.3
Benkert, J.4
Dougalis, A.5
DeZio, R.6
Snutch, T.P.7
Striessnig, J.8
Liss, B.9
-
19
-
-
34347359673
-
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
-
Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature. 2007; 447:1081-6.
-
(2007)
Nature
, vol.447
, pp. 1081-1086
-
-
Chan, C.S.1
Guzman, J.N.2
Ilijic, E.3
Mercer, J.N.4
Rick, C.5
Tkatch, T.6
Meredith, G.E.7
Surmeier, D.J.8
-
20
-
-
34250828950
-
Parkinson's disease: return of an old prime suspect
-
Sulzer D, Schmitz Y. Parkinson's disease: return of an old prime suspect. Neuron. 2007; 55:8-10.
-
(2007)
Neuron
, vol.55
, pp. 8-10
-
-
Sulzer, D.1
Schmitz, Y.2
-
21
-
-
70350780212
-
alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells
-
Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung CC, Pearson HA, Boyle JP, Robinson P, Peers C. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem. 2009; 111:1192-201.
-
(2009)
J Neurochem
, vol.111
, pp. 1192-1201
-
-
Hettiarachchi, N.T.1
Parker, A.2
Dallas, M.L.3
Pennington, K.4
Hung, C.C.5
Pearson, H.A.6
Boyle, J.P.7
Robinson, P.8
Peers, C.9
-
22
-
-
0141461407
-
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy
-
Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, Backx PH. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 2003; 9:1187-94.
-
(2003)
Nat Med
, vol.9
, pp. 1187-1194
-
-
Oudit, G.Y.1
Sun, H.2
Trivieri, M.G.3
Koch, S.E.4
Dawood, F.5
Ackerley, C.6
Yazdanpanah, M.7
Wilson, G.J.8
Schwartz, A.9
Liu, P.P.10
Backx, P.H.11
-
23
-
-
0033546223
-
Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload
-
Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res. 1999; 84:1302-9.
-
(1999)
Circ Res
, vol.84
, pp. 1302-1309
-
-
Tsushima, R.G.1
Wickenden, A.D.2
Bouchard, R.A.3
Oudit, G.Y.4
Liu, P.P.5
Backx, P.H.6
-
24
-
-
84879971693
-
Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins
-
Hurley MJ, Brandon B, Gentleman SM, Dexter DT. Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain. 2013; 136:2077-97.
-
(2013)
Brain
, vol.136
, pp. 2077-2097
-
-
Hurley, M.J.1
Brandon, B.2
Gentleman, S.M.3
Dexter, D.T.4
-
25
-
-
34548767817
-
Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures
-
Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, Van der Schyf CJ. Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res. 2007; 32:1686-93.
-
(2007)
Neurochem Res
, vol.32
, pp. 1686-1693
-
-
Gaasch, J.A.1
Geldenhuys, W.J.2
Lockman, P.R.3
Allen, D.D.4
Van der Schyf, C.J.5
-
26
-
-
84870289577
-
Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats
-
Ma Z, Zhou Y, Xie J. Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats. Neurotox Res. 2012; 22:274-9.
-
(2012)
Neurotox Res
, vol.22
, pp. 274-279
-
-
Ma, Z.1
Zhou, Y.2
Xie, J.3
-
27
-
-
33751261593
-
Role of voltage-gated L-type Ca2+ channel isoforms for brain function
-
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N. Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans. 2006; 34:903-9.
-
(2006)
Biochem Soc Trans
, vol.34
, pp. 903-909
-
-
Striessnig, J.1
Koschak, A.2
Sinnegger-Brauns, M.J.3
Hetzenauer, A.4
Nguyen, N.K.5
Busquet, P.6
Pelster, G.7
Singewald, N.8
-
29
-
-
0345714885
-
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
-
Ke Y, Ming QZ. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2003; 2:246-53.
-
(2003)
Lancet Neurol
, vol.2
, pp. 246-253
-
-
Ke, Y.1
Ming, Q.Z.2
-
30
-
-
0242712032
-
[Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice]. [Article in Chinese]
-
Jiang H, Qian ZM, Xie JX. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice]. [Article in Chinese]. Sheng Li Xue Bao. 2003; 55:571-6.
-
(2003)
Sheng Li Xue Bao
, vol.55
, pp. 571-576
-
-
Jiang, H.1
Qian, Z.M.2
Xie, J.X.3
-
31
-
-
59449106920
-
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms
-
Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009; 75:407-14.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 407-414
-
-
Sinnegger-Brauns, M.J.1
Huber, I.G.2
Koschak, A.3
Wild, C.4
Obermair, G.J.5
Einzinger, U.6
Hoda, J.C.7
Sartori, S.B.8
Striessnig, J.9
-
33
-
-
84944810279
-
Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra
-
Sun XC, Ren XF, Chen L, Gao XQ, Xie JX, Chen WF. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. J Steroid Biochem Mol Biol. 2016; 155:94-103.
-
(2016)
J Steroid Biochem Mol Biol
, vol.155
, pp. 94-103
-
-
Sun, X.C.1
Ren, X.F.2
Chen, L.3
Gao, X.Q.4
Xie, J.X.5
Chen, W.F.6
-
34
-
-
59049094805
-
Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins
-
Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int. 2009; 54:43-8
-
(2009)
Neurochem Int
, vol.54
, pp. 43-48
-
-
Wang, J.1
Xu, H.M.2
Yang, H.D.3
Du, X.X.4
Jiang, H.5
Xie, J.X.6
-
35
-
-
0026781572
-
A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin
-
Crawford GD, Le WD, Smith RG, Xie WJ, Stefani E, Appel SH. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci. 1992; 12: 3392-8
-
(1992)
J Neurosci
, vol.12
, pp. 3392-3398
-
-
Crawford, G.D.1
Le, W.D.2
Smith, R.G.3
Xie, W.J.4
Stefani, E.5
Appel, S.H.6
-
36
-
-
33748548397
-
Smallmolecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake
-
Wetli HA, Buckett PD, Wessling-Resnick M. Smallmolecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem Biol. 2006; 13:965-72
-
(2006)
Chem Biol
, vol.13
, pp. 965-972
-
-
Wetli, H.A.1
Buckett, P.D.2
Wessling-Resnick, M.3
-
37
-
-
77949261597
-
Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent
-
Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Cell Res. 2010; 20:345-56
-
(2010)
Cell Res
, vol.20
, pp. 345-356
-
-
Jiang, H.1
Song, N.2
Xu, H.3
Zhang, S.4
Wang, J.5
Xie, J.6
-
38
-
-
0034680828
-
Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool
-
Picard V, Govoni G, Jabado N, Gros P. Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J Biol Chem. 2000; 275:35738-45
-
(2000)
J Biol Chem
, vol.275
, pp. 35738-35745
-
-
Picard, V.1
Govoni, G.2
Jabado, N.3
Gros, P.4
|